17101228|t|Critical role of methionine-722 in the stimulation of human brain G-proteins and neurotoxicity induced by London familial Alzheimer's disease (FAD) mutated V717G-APP(714-723).
17101228|a|We have demonstrated earlier that V717G-APP(714-723), the membrane fragment of the V717G ("London") familial Alzheimer's disease (FAD) mutant of amyloid precursor protein (APP), is a potent stimulator of G-proteins in human brain membranes. In this study, we tested the hypothesis that Met-722 in the V717G-APP(714-723) peptide (P2) plays a critical role in the P2-induced oxidative stimulation of G-proteins in the human temporal cortex membranes and in the neurotoxicity of the peptide in differentiated PC12 and cerebellar granular cells. We found that 10 microM P3, the Met-722 sulfoxide analog of P2, produced a twofold lower stimulation of G-proteins ([(35)S]-GTPgammaS binding) in control temporal cortex membranes compared with 10 microM P2. The stimulatory effect of 10 microM P4, the Met-722 sulfone analog of P2, was 2.5-fold lower than the effect of P2. In Alzheimer's disease (AD) temporal cortex, the P3 and P4 stimulation of G-proteins was slightly weaker than the P2 stimulation. Substitution of the Met-722 S-atom in P2 by -CH(2)- group (P5) led to the disappearance of P2 stimulatory effect on G-proteins. Glutathione (GSH), melatonin (Mel), desferrioxamine (DFO) and 17-beta-estradiol (17betaE) significantly reduced P2 stimulatory effect on G-proteins in human brain. Only DFO and Mel were able to reduce the moderate stimulation of G-proteins by P3, whereas none of the tested antioxidants influenced the weak stimulation by P4. P2 at 100 microM induced a 40% decrease in PC12 cell viability as revealed by MTT assay, the effect being significantly higher than that of P3 or P4, whereas P1 (wild-type APP(714-723)) did not affect cell viability. Trypan Blue exclusion assay demonstrated that 10 microM P2 and P3 induced 3.8- and 3.5-fold death in the cerebellar granular cells as compared with the respective control values. P1 and P4 at 10 microM induced 1.7- and 2.3-fold increase in cell death, respectively. Treatment of the cerebellar granular cells with pertussis toxin decreased the high neurotoxicity of P2 and P3, whereas the low toxicity of P1 and P4 was not influenced. These results support the hypothesis that the G-protein stimulatory effect and neurotoxicity of "London"-mutated V717G-APP(714-723) (P2) and its Met-722 oxidized analogs involve oxidative-dependent and oxidative-independent mechanisms and the oxidation state of Met-722 plays a critical role in determining the mechanism.
17101228	54	59	human	Species	9606
17101228	81	94	neurotoxicity	Disease	MESH:D020258
17101228	113	141	familial Alzheimer's disease	Disease	MESH:D000544
17101228	143	146	FAD	Disease	MESH:D000544
17101228	156	161	V717G	ProteinMutation	tmVar:p|SUB|V|717|G;HGVS:p.V717G;VariantGroup:0;CorrespondingGene:351;RS#:63749964;CorrespondingSpecies:9606;CA#:127793
17101228	210	215	V717G	ProteinMutation	tmVar:p|SUB|V|717|G;HGVS:p.V717G;VariantGroup:0;CorrespondingGene:351;RS#:63749964;CorrespondingSpecies:9606;CA#:127793
17101228	259	264	V717G	ProteinMutation	tmVar:p|SUB|V|717|G;HGVS:p.V717G;VariantGroup:0;CorrespondingGene:351;RS#:63749964;CorrespondingSpecies:9606;CA#:127793
17101228	276	304	familial Alzheimer's disease	Disease	MESH:D000544
17101228	306	309	FAD	Disease	MESH:D000544
17101228	321	346	amyloid precursor protein	Gene	351
17101228	394	399	human	Species	9606
17101228	477	482	V717G	ProteinMutation	tmVar:p|SUB|V|717|G;HGVS:p.V717G;VariantGroup:0;CorrespondingGene:351;RS#:63749964;CorrespondingSpecies:9606;CA#:127793
17101228	505	507	P2	Chemical	MESH:C020845
17101228	538	540	P2	Chemical	MESH:C020845
17101228	592	597	human	Species	9606
17101228	635	648	neurotoxicity	Disease	MESH:D020258
17101228	682	686	PC12	CellLine	CVCL:0481
17101228	742	744	P3	Chemical	-
17101228	750	767	Met-722 sulfoxide	Chemical	-
17101228	778	780	P2	Chemical	MESH:C020845
17101228	834	851	[(35)S]-GTPgammaS	Chemical	-
17101228	922	924	P2	Chemical	MESH:C020845
17101228	962	964	P4	Chemical	MESH:C015586
17101228	970	985	Met-722 sulfone	Chemical	-
17101228	996	998	P2	Chemical	MESH:C020845
17101228	1038	1040	P2	Chemical	MESH:C020845
17101228	1045	1064	Alzheimer's disease	Disease	MESH:D000544
17101228	1066	1068	AD	Disease	MESH:D000544
17101228	1091	1093	P3	Chemical	-
17101228	1098	1100	P4	Chemical	MESH:C015586
17101228	1156	1158	P2	Chemical	MESH:C020845
17101228	1210	1212	P2	Chemical	MESH:C020845
17101228	1263	1265	P2	Chemical	MESH:C020845
17101228	1300	1311	Glutathione	Chemical	MESH:D005978
17101228	1313	1316	GSH	Chemical	MESH:D005978
17101228	1319	1328	melatonin	Chemical	MESH:D008550
17101228	1330	1333	Mel	Chemical	MESH:D008550
17101228	1336	1351	desferrioxamine	Chemical	MESH:D003676
17101228	1353	1356	DFO	Chemical	MESH:D003676
17101228	1362	1379	17-beta-estradiol	Chemical	MESH:D004958
17101228	1381	1388	17betaE	Chemical	MESH:D004958
17101228	1412	1414	P2	Chemical	MESH:C020845
17101228	1451	1456	human	Species	9606
17101228	1469	1472	DFO	Chemical	MESH:D003676
17101228	1477	1480	Mel	Chemical	MESH:D008550
17101228	1543	1545	P3	Chemical	-
17101228	1622	1624	P4	Chemical	MESH:C015586
17101228	1626	1628	P2	Chemical	MESH:C020845
17101228	1669	1673	PC12	CellLine	CVCL:0481
17101228	1704	1707	MTT	Chemical	MESH:C070243
17101228	1766	1768	P3	Chemical	-
17101228	1772	1774	P4	Chemical	MESH:C015586
17101228	1784	1786	P1	Chemical	MESH:C480041
17101228	1843	1854	Trypan Blue	Chemical	MESH:D014343
17101228	1899	1901	P2	Chemical	MESH:C020845
17101228	1906	1908	P3	Chemical	-
17101228	2022	2024	P1	Chemical	MESH:C480041
17101228	2029	2031	P4	Chemical	MESH:C015586
17101228	2192	2205	neurotoxicity	Disease	MESH:D020258
17101228	2209	2211	P2	Chemical	MESH:C020845
17101228	2216	2218	P3	Chemical	-
17101228	2236	2244	toxicity	Disease	MESH:D064420
17101228	2248	2250	P1	Chemical	MESH:C480041
17101228	2255	2257	P4	Chemical	MESH:C015586
17101228	2357	2370	neurotoxicity	Disease	MESH:D020258
17101228	2391	2396	V717G	ProteinMutation	tmVar:p|SUB|V|717|G;HGVS:p.V717G;VariantGroup:0;CorrespondingGene:351;RS#:63749964;CorrespondingSpecies:9606;CA#:127793
17101228	2411	2413	P2	Chemical	MESH:C020845
17101228	Negative_Correlation	MESH:C020845	MESH:D008550
17101228	Association	MESH:D000544	RS#:63749964;HGVS:p.V717G;CorrespondingGene:351
17101228	Positive_Correlation	MESH:D020258	RS#:63749964;HGVS:p.V717G;CorrespondingGene:351
17101228	Negative_Correlation	MESH:C020845	MESH:D004958
17101228	Association	MESH:C015586	MESH:D000544
17101228	Comparison	MESH:C015586	MESH:C020845
17101228	Negative_Correlation	MESH:C020845	MESH:D003676
17101228	Negative_Correlation	MESH:C020845	MESH:D005978
17101228	Association	MESH:C020845	MESH:D000544
17101228	Association	MESH:D000544	351
17101228	Association	MESH:D020258	351

